Skip to content

Bimectin is a brand name submitted for classification; no verifiable brand evidence was supplied.

Last updated October 30, 2026

AI crawler reads

2requests

1companies
  • Anthropic2
Profile
2
Controversies
0
JSON · MD
0
First read
Nov 4, 2026
Latest read
Nov 4, 2026

From this site's server log

Overview

The dossier request names "Bimectin" as a commercial brand, but the supplied evidence contains no reference to any entity by that name. The two snippets provided are unrelated Chinese-language news articles: one about an OpenAI report on a Hugging Face security incident, and one about shampoo frequency and scalp health research. Neither mentions Bimectin, a company, a product line, an owner, a headquarters, or a market. Because the identity of the subject cannot be established from the evidence, and because the name could plausibly refer to a veterinary antiparasitic product line (a common use of the "-mectin" suffix in animal-health trademarks) without any supporting source here, no substantive brand claims are made. This entry is intentionally minimal and flagged for review. A future revision should only be written once a verifiable source — an official product page, a regulatory authorization record, a distributor listing, or a trademark registration — is supplied that ties the name Bimectin to a specific commercial offering and its owner.

Recent events

  • FDA Issues Emergency Use Authorization for Bimectin Injection to Prevent New World Screwworm in Cattle[3]

    The U.S. Food and Drug Administration issued an Emergency Use Authorization for Bimectin (ivermectin) injection, sponsored by Bimeda Animal Health Ltd., for the prevention of New World screwworm infestations in cattle when administered within 24 hours of birth, at castration, or at the appearance of a wound. The authorization is not for use in lactating dairy cows or calves processed for veal, and requires a 35-day slaughter withdrawal time.

Read more

Sources3 sources

Cite this profile: Cite the canonical profile. /brand-wiki/bimectin · Editorial policy · How profiles are compiled